Back to Search
DOUGLAS FELTNER, MD
MD
Psychiatry Physician
NPI: 1568534071Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
4301075381(MI)
Research & Publications (20)
Long-term efficacy of pregabalin in generalized anxiety disorder.
PMID 18090504·Int Clin Psychopharmacol·2008
4-observational
A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder.
PMID 12826986·J Clin Psychopharmacol·2003
3-trial
Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial.
PMID 19423131·J Psychiatr Res·2009
4-observational
Clinical evaluation of the Daily Assessment of Symptoms-Anxiety (DAS-A): a new instrument to assess the onset of symptomatic improvement in generalized anxiety disorder.
PMID 19228175·CNS Neurosci Ther·2009
4-observational
The use of a clinical utility index to compare insomnia compounds: a quantitative basis for benefit-risk assessment.
PMID 19078947·Clin Pharmacol Ther·2009
4-observational
A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression.
PMID 18413705·Am J Psychiatry·2008
2-rct
Development and evaluation of the Daily Assessment of Symptoms - Anxiety (DAS-A) scale to evaluate onset of symptom relief in patients with generalized anxiety disorder.
PMID 18061206·J Psychiatr Res·2008
8-other
The patient experience of depression and remission: focus group results.
PMID 17700296·J Nerv Ment Dis·2007
4-observational
Comments on "Presidential address: advocacy as leadership".
PMID 17267802·Am J Psychiatry·2007
8-other
Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission.
PMID 17222465·Trends Pharmacol Sci·2007
6-review
Evaluation of the abuse potential of pagoclone, a partial GABAA agonist.
PMID 16702891·J Clin Psychopharmacol·2006
2-rct
A statistical approach for classifying change in cognitive function in individuals following pharmacologic challenge: an example with alprazolam.
PMID 16572266·Psychopharmacology (Berl)·2006
2-rct
Conserved regulatory elements establish the dynamic expression of Rpx/HesxI in early vertebrate development.
PMID 16527264·Dev Biol·2006
7-preclinical
How modeling and simulation have enhanced decision making in new drug development.
PMID 16283534·J Pharmacokinet Pharmacodyn·2005
6-review
Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
PMID 16143734·Arch Gen Psychiatry·2005
3-trial
A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam.
PMID 15912482·Hum Psychopharmacol·2005
3-trial
Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing.
PMID 15738746·J Clin Psychopharmacol·2005
3-trial
Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study.
PMID 15206660·J Clin Psychopharmacol·2004
3-trial
Incorporating the assessment of abuse liability into the drug discovery and development process.
PMID 12759198·Drug Alcohol Depend·2003
6-review
Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
PMID 12611835·Am J Psychiatry·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 21985 DALEVIEW DR
NOVI, MI 48374 - Phone
- (224) 619-4264
Quick Facts
- NPI
- 1568534071
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile